Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Healthcare Fiscal And Regulatory topic
No spam. Unsubscribe anytime.
Committee advances omnibus health bill after amendments and recommit to appropriations
Summary
SB 173, an expansive health package with provisions on anesthesia time, hospital community‑benefit reporting, clinical peer review standards, and neuroplasticin research, passed the Senate health committee as amended and was recommitted to Appropriations for further work.
Senator Johnson presented SB 173 as an omnibus bill aimed at several health‑system reforms, including prohibiting insurer rules that cap anesthesia time billing, strengthening hospital reporting on charity care and community benefit, clarifying clinical peer‑to‑peer standards, and creating a framework for researching neuroplasticin substances under federal "right to try" authorities.
Sponsor and witnesses described multiple amendments taken by consent that removed or narrowed provisions on physical therapy, pharmacy benefit manager vertical integration and certain pathway/AI provisions. Supporters — physicians, specialty societies, and hospital leaders — urged stronger clinical‑peer disclosure (name, license, specialty) and safeguards to ensure utilization review decisions are not made solely by artificial intelligence.
Several providers pressed for amendments to protect 340B revenue streams for safety‑net clinics; the Damien Center warned that shifting 340B funds into the Medicaid budget could threaten clinic operations. The sponsor acknowledged community‑benefit language remained contested and signaled willingness to revise it.
After discussion and brief debate, the committee passed SB 173 as amended and recommitted the measure to Appropriations, recording a 10–0 vote. Committee discussion emphasized follow‑up work on the community‑benefit definition and potential technical fixes.
